Page 1333 - Clinical Immunology_ Principles and Practice ( PDFDrive )

1294 Part ElEvEn Diagnostic Immunology

24. Mantoux C. Intradermoreaction de la tuberculose. CR Acad Sci 45. Thorpe S, Heath A, Fox B, et al. The 3rd international standard for serum
1908;147:355. IgE: international collaborative study to evaluate a candidate preparation.
25. Turkeltaub PC, Rastogi SC, Baer H, et al. A standardized quantitative skin Clin Chem Lab Med 2014;52:1283–9.
test assay of allergen potency and stability. Studies on the allergen 46. Kober A, Perborn H. Quantitation of mouse-human chimeric
dose-response curve and effect of wheal, erythema and patient selection allergen-specific IgE antibodies with ImmunoCAP technology. J Allergy
on assay results. J Allergy Clin Immunol 1982;70:343. Clin Immunol 2006;117:S219, [Abstract 845].
26. Slater JE, Menzies SL, Bridgewater J, et al. The US Food and Drug 47. Merrett J, Merrett TG. Phadiatop—a novel antibody screening test.
Administration review of the safety and effectiveness of nonstandardized Clin Allergy 1987;17:409–16.
allergen extracts. J Allergy Clin Immunol 2012;129:1014–19. 48. Szefler SJ, Wenzel S, Brown R, et al. Asthma outcomes: biomarker.
27. McCann WA, Ownby DR. The reproducibility of the allergy skin test J Allergy Clin Immunol 2012;129:S9–23.
scoring and interpretation by board-certified/board-eligible allergists. 49. Hiller R, Laffer S, Harwanegg C, et al. Microarrayed allergen molecules:
Ann Allergy Asthma Immunol 2002;89:368–71. diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414–16.
28. van Kampen V, de Blay F, Folletti I, et al. EAACI position paper: skin 50. Martínez-Aranguren R, Lizaso MT, Goikoetxea MJ, et al. Is the
prick testing in the diagnosis of occupational type I allergies. Allergy determination of specific IgE against components using ISAC 112 a
2013;68:580–4. reproducible technique? PLoS ONE 2014;9:e88394.
29. Cockcroft DW. Bronchial challenge testing. In: Adkinson NF Jr, Bochner 51. Chapman MD, Wuenschmann S, King E, et al. Technological innovations
BS, Burks AW, et al, editors. Middleton’s allergy: principles and practice. for high-throughput approaches to in vitro allergy diagnosis. Curr Allergy
8th ed. Philadelphia, PA: Elsevier Saunders; 2014. p. 1042. Asthma Rep 2015;15:36.
30. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and 52. Hamilton RG, Kleine-Tebbe J. Methods for IgE antibody testing:
exercise challenge testing—1999. Am J Respir Crit Care Med singleplex and multiplex assays. In: Matricardi P, Kleine-Tebbe J, Ollert
2000;161:309–29. M, et al, editors. Handbook on molecular allergology. Pediatr Allergy
31. Scadding GW, Hansel TT, Durham SR. Nasal Provocation Testing. In: Immunology May 27, 2016;23:1–250.
Adkinson NF Jr, Bochner BS, Burks AW, et al, editors. Middleton’s allergy: 53. Hamilton RG. Clinical laboratories worldwide need to report IgE
principles and practice. 8th ed. Philadelphia, PA: Elsevier Saunders; 2014. antibody results on clinical specimens as analytical results and not
p. 652. use differential positive thresholds. J Allergy Clin Immunol
32. Wood RA. Oral food challenge testing. In: Adkinson NF Jr, Bochner BS, 2015;136:811–12, 9.
Burks AW, et al, editors. Middleton’s allergy: principles and practice. 8th 54. Hamilton RG. Responsibility for quality IgE antibody results rests
ed. Philadelphia, PA: Elsevier Saunders; 2014. p. 1357. ultimately with the referring physician. Ann Allergy Asthma Immunol
33. Nowak-Wegrzyn A, Burks AW, Sampson HA. Reactions to foods. In: 2001;86:353–4.
Adkinson NF Jr, Bochner BS, Burks AW, et al, editors. Middleton’s allergy: 55. Nordlee JA, Taylor SL, Jones RT, et al. Allergenicity of various peanut
principles and practice. 8th ed. Philadelphia, PA: Elsevier Saunders; 2014. products as determined by RAST inhibition. J Allergy Clin Immunol
p. 1310. 1981;68:376–82.
34. Stapel SO, Asero R, Ballmer-Weber BK, et al. Testing for IgG4 against 56. Charous BL, Schuenemann PJ, Swanson MC. Passive dispersion of latex
foods is not recommended as a diagnostic tool: EAACI Task Force aeroallergen in a healthcare facility. Ann Allergy Asthma Immunol
Report. Allergy 2008;63:793–6. 2000;85:285–90.
35. Sampson HA. Utility of food specific IgE concentrations in 57. Hamilton RG, Wisenauer JA, Golden DB, et al. Selection of Hymenoptera
predicting symptomatic food allergy. J Allergy Clin Immunol venoms for immunotherapy based on patient’s IgE antibody
2001;107:891. cross-reactivity. J Allergy Clin Immunol 1993;92:651.
36. Hamilton RG, Mudd K, White MA, et al. Extension of food 58. Muller UR, Johansen N, Petersen AB, et al. Hymenoptera venom allergy:
allergen-specific IgE ranges from the ImmunoCAP to the IMMULITE analysis of double positivity to honey bee and Vespula venom by
System. Ann Allergy Asthma Immunol 2011;107:139–44. estimation of IgE antibodies to species-specific major allergens Api m1
37. Participants summary report. College of American pathologists, and Ves v5. Allergy 2009;64:543–8.
diagnostic allergy (SE) survey, Cycle B. Northfield, IL: College of 59. Ollert M, Blank S. Anaphylaxis to insect venom allergens: role of
American Pathologists; 2015. molecular diagnostics. Curr Allergy Asthma Rep 2015;15:26.
38. Chang TW, Davis FM, Sun NC, et al. Monoclonal antibodies specific for 60. Caruso B, Bonadonna P, Bovo C, et al. Wasp venom allergy screening
human IgE producing B cells: a potential therapeutic for IgE mediated with recombinant allergen testing. Diagnostic performance of rPol d 5
allergic diseases. Biotechnology (NY) 1990;8:122–6. and rVes v 5 for differentiating sensitization to Vespula and Polistes
39. Hamilton RG. Accuracy of US Food and Drug Administration cleared IgE subspecies. Clin Chim Acta 2016;435:170–3.
antibody assays in the presence of anti-IgE (omalizumab). J Allergy Clin 61. Savi E, Peveri S, Makri E, et al. Comparing the ability of molecular
Immunol 2006;117:759–66. diagnosis and CAP-inhibition in identifying the really causative venom in
40. Baker DL, Peng K, Cheu M, et al. Evaluation of two commercial patients with positive tests to Vespula and Polistes species. Clin Mol
omalizumab/free IgE immunoassays: implications for use during therapy. Allergy 2016;14:3.
Curr Med Res Opin 2014;30:913–22. 62. Sobotka AK, Valentine MD, Ishizaka K, et al. Measurement of
41. Hamilton RG. Monitoring allergic patients on omalizumab with free and IgG-blocking antibodies: development and application of a
total serum IgE measurements. J Allergy Clin Immunol Pract radioimmunoassay. J Immunol 1976;117:84–90.
2016;4:366–8. 63. James LK, Shamji MH, Walker SM, et al. Long-term tolerance
42. Radauer C, Bublin M, Wagner S, et al. Allergens are distributed into few after allergen immunotherapy is accompanied by selective
protein families and possess a restricted number of biochemical persistence of blocking antibodies. J Allergy Clin Immunol
functions. J Allergy Clin Immunol 2008;121:847–52. 2011;127:509–16.
43. Kleine-Tebbe J, Matricardi PM, Hamilton RG. Allergy work-up including 64. Golden DBK, Lawrence ID, Hamilton RG, et al. Clinical correlation of the
component-resolved diagnosis: how to make allergen-specific venom-specific IgG antibody level during maintenance venom
immunotherapy more specific. Immunol Allergy Clin North Am immunotherapy. J Allergy Clin Immunol 1992;90:386–91.
2016;36:191–203. 65. Craig CS, Schwartz LB. Tryptase and chymase: markers of distinct types
44. European Academy of Asthma Allergy and Clinical Immunology working of human mast cells. Immunol Res 1989;8:130.
group. Matricardi P, Kleine-Tebbe J, Ollert M, et al, editors. Handbook on 66. Sprung J, Weingarten TN, Schwartz LB. Presence or absence of elevated
molecular allergology. Pediatr Allergy Immunology May 27, acute total serum tryptase by itself is not a definitive marker for an
2016;23:1–250. allergic reaction. Anesthesiology 2015;122:713–14.